Opus Genetics, Inc.
IRD
31 insider filings · Latest: Jul 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18 8:12 PM | Joseph K SchachleChief Operating Officer | Sale | 3,719 | $5.25 | $19.5K | 300,781(D) | View → |
| Mar 16, 2026 | Mar 18 8:11 PM | Rabourn Amy ZarembaHead of Fin. Quality Assurance | Sale | 2,816 | $5.25 | $14.8K | 190,312(D) | View → |
| Mar 16, 2026 | Mar 18 8:10 PM | George MagrathDirector, Chief Executive Officer | Sale | 24,438 | $5.21 | $127.3K | 1,750,855(D) | View → |
| Mar 16, 2026 | Mar 18 8:09 PM | Ashwath JayagopalChief Scientific & Dev. Ofc. | Sale | 3,719 | $5.12 | $19.0K | 516,775(D) | View → |
| Mar 16, 2026 | Mar 16 8:54 PM | Magrath George | Proposed Sale | 24,438 | $5.21 | $127.3K | — | View → |
| Dec 29, 2025 | Dec 31 9:33 PM | Cam GallagherDirector | Purchase | 164,000 | $1.97 | $323.7K | 83,000(I) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
No transactions found.